Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System

Biochemistry, Genetics and Molecular Biology

• Tumor Suppressor Protein 100%
• CRISPR 100%
• Mammalian Target of Rapamycin 66%
• Cancer Cell 66%
• Epigenetics 33%
• Promoter Region 33%
• Binding Site 33%
• Colony Formation 33%
• MAPK Signaling 33%
• Cas9 33%
• mTOR Signaling 33%
• Carcinogenesis 33%
• Protein Kinase B 33%
• Guide RNA 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Melanoma 100%
• Tumor Suppressor Protein 100%
• Triple Negative Breast Cancer 50%
• Binding Site 25%
• Malignant Neoplasm 25%
• Mammalian Target of Rapamycin Inhibitor 25%
• Guide RNA 25%
• Carcinogenesis 25%
• Protein Kinase B 25%